Neuropathic Pain Associated With Spinal Cord Injury — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for neuropathic pain associated with spinal cord injury. 18 active patents protecting 1 drugs from 1+ originators. First major cliff: 2026. Daily refresh.

Originators in Neuropathic Pain Associated With Spinal Cord Injury

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating neuropathic pain associated with spinal cord injury. Each bar = one year. Y-axis scaled to peak year (9 patents).

Approved drugs ranked by patent estate

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Related

• Neuropathic Pain Associated With Spinal Cord Injury — full disease profile
• AI Patent Landscape Report — type "neuropathic pain associated with spinal cord injury" for an AI exec memo
• Company Patent Rankings
• Biosimilar Opportunity Scanner